康龍化成(03759.HK)一季度淨利增32.54%至3.06億元 新簽訂單金額同比增長超10%
格隆匯4月27日丨康龍化成(03759.HK)發佈2025年第一季度報告,報告期內,公司實現營業收入人民幣 30.99億元,同比增長16.03%;歸屬於上市公司股東的淨利潤人民幣3.06億元,同比增長32.54%;歸屬於上市公司股東的扣除非經常性損益的淨利潤人民幣 2.92億元,同比增長56.08%,基本每股收益人民幣0.1736元。
2025年第一季度,公司位於中國的、服務於全球客戶的實驗室和工廠,收入同比增長15.71%,佔公司營業收入的87.74%;公司位於海外的實驗室和工廠,收入同比增長18.33%,佔營業收入的12.26%。
按照客戶類型劃分,2025年第一季度,公司來自全球前20大製藥企業收入4.56億元,同比增長29.05%,佔公司營業收入的14.71%;來自其他客戶的收入26.43億元,同比增長14.04%,佔公司營業收入的85.29%,其中,新客戶貢獻收入佔營業收入的1.32%。按客戶所在區域劃分,2025年第一季度,公司來自北美客戶的收入20.03億元,同比增長16.81%,佔公司營業收入的64.65%;來自歐洲客戶(含英國)的收入5.69億元,同比增長26.57%,佔公司營業收入的18.36%;來自中國客戶的收入4.57億元,同比增長13.15%,佔公司營業收入的14.74%;來自其他地區客戶的收入6967.79萬元,佔公司營業收入的2.25%。公司堅持「全流程、一體化、國際化、多療法」的發展戰略,持續秉持以客戶需求爲導向,深化全球化佈局,強化技術平臺建設。報告期內,公司新簽訂單金額同比增長超過10%,其中,實驗室服務和CMC(小分子CDMO)服務新簽訂單同比增長均超過10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.